Product Images Medi First Plus Allergy Relief

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Medi First Plus Allergy Relief NDC 47682-913 by Unifirst First Aid Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Medi First Plus Allergy Relief rev 2 10 22 Label

Medi First Plus Allergy Relief rev 2 10 22 Label

This is a drug information label for 24-hour allergy relief medication containing Loratadine 10mg, an antihistamine. It provides instructions on how to use the medication, warns against overdosing and prolonged use, and contains information about inactive ingredients. It also provides a contact number for inquiries. The label emphasizes the drug's effectiveness and promises to provide relief from allergy symptoms for a period of 24 hours.*

Medique Loratadine Rev 2 10 22 Label

Medique Loratadine Rev 2 10 22 Label

This is a description of a medication called Loratadine 10mg, which is an antihistamine used to treat symptoms associated with allergies such as sneezing, runny nose, and itchy eyes. It is intended for adults and children aged 6 years and older. The medication comes in tablet form, has inactive ingredients in its composition, and is packaged in tamper-evident unit-dose packets. The carton should be kept for complete medication information. If there are any questions or comments, contact the pharmaceutical company at the provided phone number. Note that some sections of the text are not readable, so the accuracy of the description may vary.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.